via MIT
A small, light-activated molecule recently tested in mice represents a new approach to eliminating clumps of amyloid protein found in the brains of Alzheimer’s disease patients. If perfected in humans, the technique could be used as an alternative approach to immunotherapy and used to treat other diseases caused by similar amyloids.
Researchers injected the molecule directly into the brains of live mice with Alzheimer’s disease and then used a specialized probe to shine light into their brains for 30 minutes each day for one week. Chemical analysis of the mouse brain tissue showed that the treatment significantly reduced amyloid protein. Results from additional experiments using human brain samples donated by Alzheimer’s disease patients supported the possibility of future use in humans.
“The importance of our study is developing this technique to target the amyloid protein to enhance clearance of it by the immune system,” said Yukiko Hori, a lecturer at the University of Tokyo and co-first author of the research recently published in Brain.
The small molecule that the research team developed is known as a photo-oxygenation catalyst. It appears to treat Alzheimer’s disease via a two-step process.
First, the catalyst destabilizes the amyloid plaques. Oxygenation, or adding oxygen atoms, can make a molecule unstable by changing the chemical bonds holding it together. Laundry detergents or other cleaners known as “oxygen bleach” use a similar chemical principle.
The catalyst is designed to target the folded structure of amyloid and likely works by cross-linking specific portions called histidine residues. The catalyst is inert until it is activated with near-infrared light, so in the future, researchers imagine that the catalyst could be delivered throughout the body by injection into the bloodstream and targeted to specific areas using light.
Second, the destabilized amyloid is then removed by microglia, immune cells of the brain that clear away damaged cells and debris outside healthy cells. Using mouse cells growing in a dish, researchers observed microglia engulfing oxygenated amyloid and then breaking it down in acidic compartments inside the cells.
“Our catalyst binds to the amyloid-specific structure, not to a unique genetic or amino acid sequence, so this same catalyst can be applied to other amyloid depositions,” said Professor Taisuke Tomita, who led the project at the University of Tokyo.
The American Society of Clinical Oncology estimates that each year in the U.S., 4,000 people are diagnosed with diseases caused by amyloid outside of the brain, collectively known as amyloidosis.
The photo-oxygenation catalyst should be capable of removing amyloid protein, regardless of when or where it formed in the body. Although some existing Alzheimer’s disease treatments can slow the formation of new amyloid plaques, eliminating existing plaques is especially important in Alzheimer’s disease because amyloid begins aggregating years before symptoms appear.
The research team is now working to modify the design of the catalyst so it can be activated by shining light through the skull.
Original Article: Power of light and oxygen clears Alzheimer’s disease protein in live mice
More from: University of Tokyo
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Reducing amyloid protein
- A Common Sleeping Pill May Reduce Build-Up of Alzheimer's Proteins, Study Finds
There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one that researchers are exploring with gusto.
- 5 Key Challenges Facing Black Folks with ATTR-CM
Here are five challenges to be aware of if you have been diagnosed with ATTR-CM- and then we’ll cover what we can do about ’em.
- Gene mutation may signal new genetic form of Alzheimer's disease
People who carry two copies of the gene mutation most strongly implicated in Alzheimer's disease are almost certain to develop brain changes related to the degenerative disorder, a new study says.
- How exactly does a high-fat diet increase Alzheimer's risk?
New research in mouse models of Alzheimer's disease suggests that a high-fat diet causes molecular changes that disrupt brain health.
- Managing the Patient with Amyloidosis
Amyloid protein can limit the ability of the heart ... Limit salt intake to reduce fluid retention. Get up slowly from a sitting or lying position to prevent lightheadedness or dizziness.
Go deeper with Google Headlines on:
Reducing amyloid protein
[google_news title=”” keyword=”reducing amyloid protein” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Amyloidosis
- Prothena Reports First Quarter 2024 Financial Results and Business Highlights
DUBLIN, May 08, 2024 -- ( BUSINESS WIRE )--Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein ...
- MedStar Washington Hospital Center enrolls first U.S. patient in gene-editing therapy trial for heart disease
The first U.S. heart patient involved in a study for a new gene-editing therapy directly infused inside the body has successfully been enrolled at MedStar Washington Hospital Center.
- Managing the Patient with Amyloidosis
It is important for the nurse to assess the extent of kidney involvement in amyloidosis and the development of the nephrotic syndrome. The nephrotic syndrome is suspected when there are high ...
- Drug Insight: Emerging Therapies for Amyloidosis
Amyloidosis is a clinical disorder caused by extracellular deposition of proteins that are normally soluble as insoluble, abnormal fibrils that impair organ function. More than 20 unrelated ...
- ALECT2 has a better prognosis than other types of amyloidosis
First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the ...
Go deeper with Google Headlines on:
Amyloidosis
[google_news title=”” keyword=”amyloidosis” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]